Flagellate Pattern of Toxic Erythema of Chemotherapy Due to Doxorubicin: A Case Report.
J Cutan Med Surg
; 20(5): 481-3, 2016 Sep.
Article
em En
| MEDLINE
| ID: mdl-27068228
ABSTRACT
BACKGROUND:
Doxorubicin is an antineoplastic agent frequently used in diverse cancer regimens. Cutaneous adverse effects have frequently been reported with its use. However, a flagellate-like dermatitis is not mentioned in the literature.OBJECTIVE:
The investigators report a case of toxic erythema of chemotherapy with a flagellate pattern induced by doxorubicin. METHODS ANDRESULTS:
A 75-year-old woman with endometrial cancer received doxorubicin as part of her treatment. After her third cycle, she presented a pruritic vesiculobullous eruption, with linear elements that left hyperpigmented streaks on follow-up. A biopsy was compatible with a drug eruption.CONCLUSION:
Doxorubicin is a well-known cause of toxic erythema of chemotherapy. As seen in this patient, the investigators suggest that it also be added to the list of causes of flagellate dermatosis.Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Doxorrubicina
/
Neoplasias do Endométrio
/
Toxidermias
/
Eritema
/
Antibióticos Antineoplásicos
Tipo de estudo:
Etiology_studies
Limite:
Aged
/
Female
/
Humans
Idioma:
En
Revista:
J Cutan Med Surg
Ano de publicação:
2016
Tipo de documento:
Article